Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Heyuan Sun"'
Autor:
Fangfang Li, Zongliang Liu, Heyuan Sun, Chunmei Li, Wenyan Wang, Liang Ye, Chunhong Yan, Jingwei Tian, Hongbo Wang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 10, Iss 2, Pp 289-300 (2020)
Gliomas are the most common primary intracranial neoplasms among all brain malignancies, and the microtubule affinity regulating kinases (MARKs) have become potential drug targets for glioma. Here, we report a novel dual small-molecule inhibitor of M
Externí odkaz:
https://doaj.org/article/28e42187a2b540f39d4f98edd2c9fc66
Autor:
Heyuan Sun
Publikováno v:
Journal of Legal Studies & Research. :08-33
Enterprises’ self-environmental protection compliance is a positive strategy to deal with environmental risks. With the continuous implementation of the “dual carbon” goal (Carbon Peak by 2030 and Carbon Neutrality by 2060), corporate complianc
Autor:
Heyuan Sun, Jinfeng Zuo
Publikováno v:
International Journal of Legal Developments & Allied Issues. :153-172
Urban renewal is regarded as a broad concept involving physical, social, economic and environmental aspects, which is closely related to the goal of sustainable urban development. Traditional urban renewal only focuses on the physical construction in
Autor:
Heyuan Sun, Zhiyuan Liu
Publikováno v:
Asian Law & Public Policy Review. :54-80
The corporate compliance system, an internal control mechanism to prevent, detect and stop illegal and criminal offences within a corporate, can serve to effectively solve potential criminal compliance risks in construction projects. The construction
Autor:
Hongbo Wang, Wenyan Wang, Chunmei Li, Zongliang Liu, Fangfang Li, Jingwei Tian, Heyuan Sun, Liang Ye, Chunhong Yan
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 10, Iss 2, Pp 289-300 (2020)
Gliomas are the most common primary intracranial neoplasms among all brain malignancies, and the microtubule affinity regulating kinases (MARKs) have become potential drug targets for glioma. Here, we report a novel dual small-molecule inhibitor of M
Publikováno v:
Bioanalysis. 11:679-687
Aim: Evolocumab is a human monoclonal antibody used in the treatment of cardiovascular diseases, which targeted proprotein convertase subtilisin kexin type 9. To accurately quantify free (including partially bound) and total evolocumab concentrations
Autor:
Amber Wood, Heyuan Sun, Matthew Jones, Hannah Percival, Eleanor Broadberry, Egor Zindy, Craig Lawless, Charles Streuli, Joe Swift, Keith Brennan, Andrew P. Gilmore
SummaryMicroenvironmental stiffness regulates the behaviour of both normal and cancer cells. In breast tissue, high mammographic density (HMD), which reflects greater organisation and stiffness of the periductal collagen, represents a significant ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::511a857504b1f59f763ddbab9aabd8f1
https://doi.org/10.1101/2020.10.06.327726
https://doi.org/10.1101/2020.10.06.327726
Autor:
Wenyan Wang, Zongliang Liu, Jingwei Tian, Heyuan Sun, Liang Ye, Guangying Du, Xuhui Zhuang, Lina Dong
Publikováno v:
Xenobiotica. 49:1338-1343
1. S-EPA is a sulfur-substitution analog of epacadostat (EPA), an effective small molecule indoleamine 2,3-dioxgenase1 (IDO) inhibitor. By in vitro and in vivo experiments, pharmacokinetic differences of two closely related analogs, S-EPA and EPA was
Publikováno v:
Bioanalysis. 10:1335-1344
Aim: Tryptophan (Trp) and kynurnine (Kyn) are a pair of biomarkers for indoleamine 2,3-dioxygenase which closely related to the tumor immune escape. To evaluate the effect of drugs on the indoleamine 2,3-dioxygenase activity, the specific and accurat
Autor:
Fangfang, Li, Zongliang, Liu, Heyuan, Sun, Chunmei, Li, Wenyan, Wang, Liang, Ye, Chunhong, Yan, Jingwei, Tian, Hongbo, Wang
Publikováno v:
Acta Pharmaceutica Sinica. B
Gliomas are the most common primary intracranial neoplasms among all brain malignancies, and the microtubule affinity regulating kinases (MARKs) have become potential drug targets for glioma. Here, we report a novel dual small-molecule inhibitor of M